Alopecia Areata (Patchy Hair Loss): Causes, Treatment and Prognosis

Alopecia areata (AA) affects 1-2 percent of the British population, accounting for 2% of new dermatological NHS outpatients each year.

Scientists have been studying the relationship between AA and autoimmune diseases, coeliac disease, and what causes alopecia areata for many years.

New studies show that patients who received auto immunotherapy and changed their diets experienced successful hair regrowth. We’ll go over these findings in greater depth below.

What is alopecia areata?

Alopecia areata (patchy hair loss) is an autoimmune condition in which the immune system attacks the hair follicles and leaves round, sharply defined bald patches. Unlike scarring alopecias, the follicle is only switched off, not destroyed. According to the foundational paper “Hair follicle immune privilege and its collapse” (2020), the structure is preserved, so there is fundamentally the potential for regrowth.^[1]

The lifetime prevalence worldwide is around 2%, and 2.1% in a US population study.^[2] This makes alopecia areata the most common autoimmune condition of all and the second most common form of hair loss after hereditary hair loss. In Germany, according to the announcement of the new S3 guideline (DDG, February 2026), around 170,000 people are affected, with roughly 70,000 new cases per year.^[3]

The condition can begin at any age, with the peak incidence between the ages of 10 and 30. Around 66% of those affected experience their first episode before the age of 30.^[4] Contrary to a widespread assumption, women are more often affected: a Global Burden of Disease analysis (1990 to 2021) puts their lifetime risk at around 1.9 times higher than that of men.^[5]

Alopecia areata is not contagious, not an infection and not a fungus, and it poses no direct danger to life. The main burden is psychosocial: anxiety, low mood and reduced quality of life are well documented. “Not dangerous” therefore does not mean “harmless”; the emotional strain is real and must be taken seriously.

Symptoms: how to recognise alopecia areata

Alopecia areata shows up as sharply defined, round or oval bald patches on smooth, unremarkable skin, without scaling, redness or scarring. A coin-sized gap is often noticed by chance while combing or by the hairdresser. The edges are clear and the surrounding hair looks healthy. This distinguishes the condition from inflammatory or scarring forms.

The most important warning sign is exclamation mark hairs: short hairs at the edge of active patches that taper towards the scalp and are broader at the tip. They are considered a highly characteristic sign of active disease and, according to a systematic review (2023), are detectable in 91.9% of active cases.^[6] They are not strictly conclusive, as they occasionally occur in other conditions too.

Many people notice itching, tingling or burning at the site before any visible hair loss. According to research summaries, this so-called trichodynia is reported by about 25 to 30% of patients. The symptom is often anxiety-provoking, but on its own it is no proof of alopecia areata. It can be an early sign of a new flare-up.

Some of those affected show nail changes, the frequency of which varies widely in the literature (7 to 66%, averaging around 30%). Typical are pitted nails (small dents, 53.3% in one cohort) and trachyonychia (rough sandpaper nails). Nail involvement is regarded as a rather unfavourable prognostic marker. The scalp, beard, eyelashes, eyebrows and body hair can all be affected.

Causes of alopecia areata

The cause of alopecia areata is an autoimmune reaction on the basis of a genetic predisposition, not a nutrient deficiency and not poor hair care. During the growth phase, the follicle normally has an “immune privilege”, a kind of protected zone. In alopecia areata this protection collapses, so the immune system treats its own hair as foreign.^[1]

Specifically, CD8+ NKG2D+ T cells migrate into the hair bulb and release the messenger interferon-gamma (IFN-γ), which intensifies the attack.^[7] The central signalling pathway behind this is the JAK-STAT pathway. This is precisely why modern JAK inhibitors work: they interrupt this cascade. The follicle itself remains intact throughout this process.

Alopecia areata occurs more frequently alongside other autoimmune conditions. The most common accompanying condition is autoimmune thyroid disease (6.8% in one study), followed by vitiligo (around 2.8%) and atopic dermatitis (up to 14.1%).^[8] Overall, in one clinical study 11.5% of those affected had a further autoimmune condition, compared with 7.9% in the control group.^[9] We explain this link to the thyroid in our article on hair loss caused by the thyroid.

The predisposition is the prerequisite; a trigger then sets off the flare-up. Recognised triggers include infections, hormonal changes and emotional strain. Flare-ups have also been described after a COVID-19 infection or vaccination, more often in people with a family history. However, large analyses show no generally increased risk, so a nuanced view is important here.

Does alopecia areata come from stress?

Stress is not the cause of alopecia areata, but where a predisposition already exists it can help trigger a flare-up. The underlying condition remains autoimmune.^[10] Perhaps the clearest evidence against it being “all in the mind”: alopecia areata also occurs in newborns and infants, in whom psychological stress can be ruled out as an explanation.

In an older psychodermatological study, at least 23% of patients reported a stressful life event before the onset of the condition.^[11] This figure comes from a small sample and is not suitable as a fixed causal rate. But it does show that stress can be one piece of the puzzle for some of those affected, while never being the sole explanation.

The framing “you brought this on yourself through stress” is factually wrong and is often experienced by those affected as an accusation of blame. In reality, the reverse is true: the visible hair loss itself causes considerable stress, feeding a vicious circle. Stress management is therefore a sensible supporting measure, but it does not reliably calm the autoimmune process and is no substitute for treatment.

Forms and severity of alopecia areata

Alopecia areata ranges from a single patch to complete hair loss, and the form determines prognosis and treatment. The most common and usually mildest variant is patchy alopecia areata with one or more limited patches. From there, dermatologists describe a spectrum extending to the severe, extensive forms.

• Alopecia areata (patchy): one or more round patches, usually the mildest and most common form.
• Alopecia totalis: complete loss of scalp hair.
• Alopecia universalis: complete loss of scalp and body hair.
• Ophiasis: band-shaped loss at the back of the head and hairline, prognostically unfavourable.
• Alopecia areata incognita (diffuse): a rare, diffuse form seen mainly in younger women that resembles telogen effluvium.
• Alopecia areata barbae: a special form confined to the beard, accounting for around 28% of cases according to one survey, with an average age of onset of 30 to 40 years.

Does alopecia areata grow back?

In short: yes, alopecia areata can grow back, because the follicle is not destroyed, but the chances depend heavily on the severity. With mild, patchy involvement, according to a review, spontaneous remission occurs in 30 to 50% of cases within the first 6 to 12 months, and up to 66% recover within 5 years.^[12]

The extent is decisive: with under 25% scalp involvement the remission rate is around 68%, while with over 50% involvement it is only about 8%. For alopecia totalis, universalis and the ophiasis form, spontaneous remission is under 10%. Anyone with one of these forms should not rely on “it will just grow back”.

Important for context: press reports on the new German S3 guideline (2026) summarise that a “spontaneous cure” occurs in fewer than 10% of cases.^[3] This seems to contradict the international 30 to 68% for mild cases. The reason lies in differing definitions: lasting, relapse-free recovery is rarer than visible regrowth of individual patches.

The new hair often appears thin and unpigmented at first, as light vellus hair, and only then follow repigmentation and thickening over several months. The precise timing, why the first hairs only become visible after months, is linked to the hair cycle. The following timeline shows a typical but not guaranteed course.

And to be honest: relapses are possible at any time, even after years without symptoms. A patch that has once grown back is no guarantee for the future. This is why dermatological follow-up is important, especially when new patches appear or the picture changes.

Treatment of alopecia areata

In short: the treatment of alopecia areata depends on the severity and ranges from deliberate watchful waiting through cortisone preparations and topical immunotherapy to modern JAK inhibitors. The aim is to slow the autoimmune reaction, not to “cure” at the push of a button. No over-the-counter product and no hair transplant removes the underlying condition. The choice of therapy belongs in dermatological hands.

For a small, fresh single patch, controlled watchful waiting during the first roughly 6 months is a legitimate option under the new German S3 guideline, because the chance of spontaneous remission is high here. For more extensive or rapid loss, active treatments come into play. The overview below assigns the options to the respective severity.

One point is decisive for expectations: JAK inhibitors such as baricitinib (Olumiant, CHMP recommendation May 2022) and ritlecitinib (Litfulo, EU approval September 2023, from age 12) are approved exclusively for severe alopecia areata, meaning from a SALT score of 50.^[15] They are not intended for the typical coin-sized single patch.

These agents can bring about significant regrowth in severe cases, but they carry a boxed-warning class covering cardiovascular events, cancer and thromboses, derived from data on other JAK inhibitors.^[16] Systemic cortisone is no harmless long-term solution either: relapse frequently follows once it is stopped. Decisions like these are always weighed by the doctor against the severity.

Alopecia areata vs hereditary hair loss: when a hair transplant is an option

Alopecia areata (autoimmune, round patches, often reversible) differs fundamentally from hereditary hair loss (androgenetic, a receding hairline and thinning crown). Only the hereditary type can be treated with a hair transplant at all. Anyone who discovers a bald patch should therefore first find out which type is present. Both can also occur at the same time.

For alopecia areata, a hair transplant is fundamentally not a reliable solution, not even in a seemingly quiet phase. The autoimmune process can flare up again at any time and would attack transplanted follicles just the same. In addition, the surgical stimulus can reactivate a previously dormant patch through the Köbner phenomenon. Only a confirmed androgenetic pattern is transplantable at all.

So the first step is always the question: which type is actually present? This is exactly what the free Elithair hair analysis is designed for, as a pre-filter. It looks at your visible pattern of loss and gives a first indication of whether it looks more like a hereditary pattern, which is fundamentally transplantable, or like alopecia areata or diffuse hair loss, which belongs with a dermatologist. In both cases the result points you in the right direction. It is no substitute for a medical blood test or a dermatological diagnosis, but it can clarify the direction.

When to see a doctor about alopecia areata

You should see a dermatologist for any new bald patch, for rapid or widespread loss, for involvement of the beard, eyelashes or nails, and for significant emotional strain. The dermatologist is the right point of contact for alopecia areata. They confirm the diagnosis and check for accompanying autoimmune conditions, for example via thyroid levels.

The doctor makes the diagnosis using several methods. In addition to visual inspection, trichoscopy (dermatoscopy) is often used, the most important non-invasive examination. Typical signs are yellow dots (the most common sign), black dots, exclamation mark hairs and short vellus hairs. Their decline under treatment is regarded as a good sign of response. A blood test can additionally rule out other causes.

Myth vs fact about alopecia areata

Plenty of persistent misconceptions circulate around alopecia areata, from home remedies to fear of contagion. The comparison below places the most common claims in context based on the evidence. It is no substitute for a conversation with your doctor, but it helps to sort out common misinformation and ease unnecessary worries.

Frequently asked questions about alopecia areata

Sources

This article is for general information and is no substitute for a medical diagnosis or treatment. Alopecia areata requires dermatological assessment. Last updated: 2026.